About this trial
The goal of this clinical trial is to learn if the "Mittin" intervention can improve women's ability to manage their fertility in line with their preferences among women aged 15-49 using hormonal contraceptives or intrauterine devices and attending public health centers in Addis Ababa, Ethiopia. The main question it aims to answer is: Does the Mittin intervention increase preference-aligned fertility management, contraceptive method satisfaction, and preferred contraceptive method use among participants compared to standard care?
Researchers will compare women's outcomes in health centers providing the Mittin intervention to women's outcomes in health centers that offer standard care to see if Mittin improves women's ability to act in line with their contraceptive preferences.
Participants will
* Receive either standard contraception services (control arm) or enhanced services (intervention arm) * Participate in a survey at the beginning of the study * Participate in surveys 4 and 8 months later
Eligibility criteria
Qualifiers
Woman
Started or continued using hormonal contraceptive method or copper IUD on day of recruitment
Ages 15-49 years
Willing to provide phone number and receive follow-up phone call
Disqualifiers
Not planning to live in Addis Ababa for the next eight months
Can not verbally communicate
Not willing to provide consent for the study
Trial design
Treatments tested in this trial
- Mittin
Treatment groups
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
St. Paul's Hospital Millennium Medical College, Ethiopia
Collaborator
Bill and Melinda Gates Foundation
Collaborator